kiny
Well-known member
Link:
https://www.nestlehealthscience.com/newsroom/press-releases/nestl-health-science-invests-in-enterome-alongside-existing-investors
20 April 2016
"Nestlé Health Science invests alongside existing investors as Enterome raises €14.5 million in Series C financing round.
Enterome will use the funds raised to advance the development of its lead drug candidate EB 8018 into first clinical studies during 2016 as a potential treatment for inflammatory bowel diseases (IBD). EB 8018 is a novel small molecule FimH antagonist licensed from Vertex that specifically targets Adherent Invasive Escherichia coli (AIEC) proliferation in the gut, one of the main causes of inflammatory colitis in IBD sufferers. AIEC is an opportunistic pathogen able to thrive in the dysbiotic gut microbiome that results as IBD develops, prolonging and exacerbating the symptoms. EB 8018 acts to restore the dysbiotic microbiome to a normal state via a novel mechanism of action whereby the adhesion of AIEC to the gut wall and its proliferation is prevented."
AIEC Video:
https://youtu.be/aTeZZ7ydmfM
https://www.nestlehealthscience.com/newsroom/press-releases/nestl-health-science-invests-in-enterome-alongside-existing-investors
20 April 2016
"Nestlé Health Science invests alongside existing investors as Enterome raises €14.5 million in Series C financing round.
Enterome will use the funds raised to advance the development of its lead drug candidate EB 8018 into first clinical studies during 2016 as a potential treatment for inflammatory bowel diseases (IBD). EB 8018 is a novel small molecule FimH antagonist licensed from Vertex that specifically targets Adherent Invasive Escherichia coli (AIEC) proliferation in the gut, one of the main causes of inflammatory colitis in IBD sufferers. AIEC is an opportunistic pathogen able to thrive in the dysbiotic gut microbiome that results as IBD develops, prolonging and exacerbating the symptoms. EB 8018 acts to restore the dysbiotic microbiome to a normal state via a novel mechanism of action whereby the adhesion of AIEC to the gut wall and its proliferation is prevented."
AIEC Video:
https://youtu.be/aTeZZ7ydmfM